61Cu-NODAGA-LM3 + Comparator

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

61Cu-NODAGA-LM3 + Comparator
Treatment and conditionWhere it standsTrials
61Cu-NODAGA-LM3 + Comparator for neuroendocrine tumorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1